Purpose: In the present study, we identified the pre-operative predictive factors of insignificant prostate cancer and we analyzed their diagnostic accuracy. Material and Methods: Of a total 343 patients who had undergone radical prostatectomy, 33 patients (9.6%) were diagnosed with insignificant cancer that was characterized by a total cancer volume ≤0.5cc, a Gleason score (GS)≤6, a T stage≤2c and no positive surgical margin. We found the statistically significant factors after comparing of preoperative clinicopathological findings between two groups and determined the diagnostic accuracy of the identified predictors. Results: Of several factors, prostate-specific antigen (PSA) level (p=0.04, odds ratio (OR)=4.3 3.589≤95%confidence interval (CI)≤5.692), PSA density (PSAD) (p=0.01, OR=6.6, 2.115≤95%CI≤278.826), biopsy GS (p=0.03, OR=4.6, 1.114≤95%CI≤12.568) and volume of the largest cancer (p=0.02, OR=5.6, 2.471≤95%CI≤9.725) were analyzed as independent predictors of insignificant cancer. The volume of the largest cancer was the most precise predictor (AUC=0.791), followed by the PSAD (AUC=0.748) and the PSA level (AUC=0.677) in the ROC (receiver operating characteristic) curve analysis. The sensitivity, specificity and positive predictive value for predicting insignificant cancer were 10.3%, 63.7% and 12.8% at a PSA level of 10ng/ml, and 44.8%, 16.8% and 26.3% at a PSAD of 0.15ng/ml/ml, and 13.8%, 53.8% and 14.2% at a volume of the largest cancer of 50%, respectively. Even with using a combination of these three factors as well as a biopsy GS≤6, only 53% of insignificant prostate cancer could be predicted preoperatively. Conclusions: In our study, PSA level, PSAD, biopsy GS and volume of the largest cancer were identified as predictors of insignificant cancer in spite of their unsatisfactory diagnostic accuracy. (Korean J Urol 2008;49: 398-403)

